Market Overview
According to DIResearch＇s in-depth investigation and research, the global Biomarkers market size will reach 100,576 Million USD in 2025 and is projected to reach 265,100 Million USD by 2032, with a CAGR of 14.85% (2025-2032). Notably, the China Biomarkers market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Biomarkers are measurable indicators, such as molecules or physiological characteristics, that are used to assess or predict various biological processes, conditions, or responses within an organism. They can be found in bodily fluids, tissues, or other biological samples and can provide valuable information about the presence, progression, or severity of a disease, as well as the efficacy of a treatment or the overall health status of an individual. Biomarkers can include molecules like proteins, enzymes, hormones, or genetic materials, as well as physiological measurements such as blood pressure, heart rate, or brain activity. By measuring and analyzing biomarkers, healthcare professionals and researchers can gain insights into the underlying mechanisms of diseases, diagnose conditions, monitor treatment responses, and make informed decisions about patient care. Biomarkers play a crucial role in personalized medicine, clinical research, and the development of new therapies, helping to improve disease detection, management, and patient outcomes.
The major global suppliers of Biomarkers include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott, Agilent Technologies, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Biomarkers. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Biomarkers market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Biomarkers market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biomarkers industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Biomarkers Include:
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Biomarkers Product Segment Include:
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Biomarker Testing
Stroke Detection Biomarkers
Antibiotic Stewardship Biomarkers
Other
Biomarkers Product Application Include:
Diagnosis
Drug Discovery
Personalized Medicine
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Biomarkers Industry PESTEL Analysis
Chapter 3: Global Biomarkers Industry Porter's Five Forces Analysis
Chapter 4: Global Biomarkers Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Biomarkers Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Biomarkers Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Biomarkers Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
- 1 Biomarkers Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Biomarkers Product by Type
- 1.2.1 Sepsis Biomarkers
- 1.2.2 Antibiotic Resistance Biomarkers
- 1.2.3 Traumatic Brain Injury (TBI) Biomarker Testing
- 1.2.4 Stroke Detection Biomarkers
- 1.2.5 Antibiotic Stewardship Biomarkers
- 1.2.6 Other
- 1.3 Biomarkers Product by Application
- 1.3.1 Diagnosis
- 1.3.2 Drug Discovery
- 1.3.3 Personalized Medicine
- 1.3.4 Other
- 1.4 Global Biomarkers Market Size Analysis (2020-2032)
- 1.5 Biomarkers Market Development Status and Trends
- 1.5.1 Biomarkers Industry Development Status Analysis
- 1.5.2 Biomarkers Industry Development Trends Analysis
- 2 Biomarkers Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Biomarkers Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Biomarkers Market Analysis by Country
- 4.1 Global Biomarkers Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Biomarkers Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Biomarkers Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.5 China Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.6 France Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.14 India Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Biomarkers Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Biomarkers Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Biomarkers Market Revenue by Key Suppliers (2021-2025)
- 5.2 Biomarkers Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Biomarkers Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Biomarkers Market Analysis by Type
- 6.1 Global Biomarkers Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Biomarkers Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Thermo Fisher Scientific Biomarkers Product Portfolio
- 7.1.3 Thermo Fisher Scientific Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Merck
- 7.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Merck Biomarkers Product Portfolio
- 7.2.3 Merck Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Bio-Rad Laboratories
- 7.3.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Bio-Rad Laboratories Biomarkers Product Portfolio
- 7.3.3 Bio-Rad Laboratories Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 QIAGEN
- 7.4.1 QIAGEN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 QIAGEN Biomarkers Product Portfolio
- 7.4.3 QIAGEN Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Roche
- 7.5.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Roche Biomarkers Product Portfolio
- 7.5.3 Roche Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Danaher Corporation
- 7.6.1 Danaher Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Danaher Corporation Biomarkers Product Portfolio
- 7.6.3 Danaher Corporation Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Siemens Healthcare
- 7.7.1 Siemens Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Siemens Healthcare Biomarkers Product Portfolio
- 7.7.3 Siemens Healthcare Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Abbott
- 7.8.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Abbott Biomarkers Product Portfolio
- 7.8.3 Abbott Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Agilent Technologies
- 7.9.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Agilent Technologies Biomarkers Product Portfolio
- 7.9.3 Agilent Technologies Biomarkers Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Biomarkers Industry Chain Analysis
- 8.2 Biomarkers Product Downstream Application Analysis
- 8.2.1 Global Biomarkers Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Biomarkers Revenue and Forecast by Application (2020-2032)
- 8.3 Biomarkers Typical Downstream Customers
- 8.4 Biomarkers Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook